Intelligent Accounts Payable from 2010 to 2025

INBS Stock  USD 1.76  0.35  16.59%   
Intelligent Bio Accounts Payable yearly trend continues to be comparatively stable with very little volatility. Accounts Payable is likely to outpace its year average in 2025. Accounts Payable is the amount Intelligent Bio Solutions owes to suppliers or vendors for products or services received but not yet paid for. It represents Intelligent Bio's short-term liabilities. View All Fundamentals
 
Accounts Payable  
First Reported
2018-06-30
Previous Quarter
1.8 M
Current Value
1.1 M
Quarterly Volatility
786.5 K
 
Covid
Check Intelligent Bio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Intelligent Bio's main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.4 M, Interest Expense of 142.9 K or Selling General Administrative of 11.2 M, as well as many indicators such as Price To Sales Ratio of 2.05, Dividend Yield of 0.0 or PTB Ratio of 0.66. Intelligent financial statements analysis is a perfect complement when working with Intelligent Bio Valuation or Volatility modules.
  
Check out the analysis of Intelligent Bio Correlation against competitors.

Latest Intelligent Bio's Accounts Payable Growth Pattern

Below is the plot of the Accounts Payable of Intelligent Bio Solutions over the last few years. An accounting item on the balance sheet that represents Intelligent Bio obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Intelligent Bio Solutions are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. It is the amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities. Intelligent Bio's Accounts Payable historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Intelligent Bio's overall financial position and show how it may be relating to other accounts over time.
Accounts Payable10 Years Trend
Slightly volatile
   Accounts Payable   
       Timeline  

Intelligent Accounts Payable Regression Statistics

Arithmetic Mean580,033
Geometric Mean498,289
Coefficient Of Variation58.83
Mean Deviation274,380
Median483,576
Standard Deviation341,208
Sample Variance116.4B
Range1.2M
R-Value0.63
Mean Square Error74.6B
R-Squared0.40
Significance0.01
Slope45,418
Total Sum of Squares1.7T

Intelligent Accounts Payable History

2025792.1 K
2024692.7 K
2023602.3 K
20221.2 M
2021715.9 K
20201.4 M
2019483.6 K

About Intelligent Bio Financial Statements

Intelligent Bio shareholders use historical fundamental indicators, such as Accounts Payable, to determine how well the company is positioned to perform in the future. Although Intelligent Bio investors may analyze each financial statement separately, they are all interrelated. The changes in Intelligent Bio's assets and liabilities, for example, are also reflected in the revenues and expenses on on Intelligent Bio's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Accounts Payable692.7 K792.1 K

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Intelligent Stock Analysis

When running Intelligent Bio's price analysis, check to measure Intelligent Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Intelligent Bio is operating at the current time. Most of Intelligent Bio's value examination focuses on studying past and present price action to predict the probability of Intelligent Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Intelligent Bio's price. Additionally, you may evaluate how the addition of Intelligent Bio to your portfolios can decrease your overall portfolio volatility.